Live Webinar: The Latest Evidence and Real-World Clinical Trial Enrollment Strategies in Platinum-Resistant Ovarian Cancer
Event Date
Tuesday, December 2, 2025
Location
Virtual Live Event
Event Time
5:00pm Eastern (2:00pm Pacific)
Completion Time
30 minutes
Specialty
Hematology-Oncology, Obstetrics & Gynecology, Pathology, Primary Care, Radiology, Surgery
Topic(s)
Oncology, Radiology
Credit Available
- 0.5 CME/CE for Physicians (ACCME)
- 0.5 CME/CE for Physician Assistants (AAPA)
- 0.5 CH/CE for Nurse Practitioners (AANP)
- 0.5 CPE for Pharmacists (ACPE + NABP)
- 0.5 CNE for Nurses (ANCC)
All other healthcare professionals completing this course will be issued a statement of participation.
Program Overview
Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.
Join two leading ovarian cancer experts for this live webinar to dive deeper into the latest clinical data on emerging agents, including novel targets and mechanisms of action, and examine their impact on treatment selection and sequencing. Examine barriers that impede equitable clinical trial enrollment and uncover strategies to expand access and enhance participation of underrepresented populations. Elevate your practice with the PROCure Emerging Therapies Clinical Trial Pocket Guide, a downloadable tool to support timely referrals and informed treatment decisions.
Learning Objectives
- Assess the evolving treatment landscape for platinum-resistant ovarian cancer (PROC)
- Describe the mechanisms of action of novel therapies for PROC, including selective glucocorticoid receptor (GR) modulators as well as folate receptor alpha (FRα)-, cadherin-6 (CDH6)-, and human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates (ADCs)
- Evaluate recent clinical trial data on the efficacy and safety of emerging agents for the treatment of PROC and implications for clinical practice
- Employ multidisciplinary strategies for addressing barriers to clinical trial enrollment and diversity, including logistical concerns and patient hesitancy
Faculty
Elizabeth (Betsy) Lee, MD - Speaker
Ritu Salani, MD, - Speaker
Carolyn Oxencis, PharmD, BCOP, FHOPA - Moderator
Kelly Valla, PharmD, BCOP – Contributing Author
Kevin O. Hwang, MD, MPH – Planner
Lisa Wakefield, MSN, APRN, FNP-BC – Planner
Annette Sophin, MSMM, PA-C – Peer Review